BRONTE, Enrico
BRONTE, Enrico
Anticancer therapy-induced vascular toxicity: VEGF inhibition and beyond
2016-01-01 DI LISI, D.; Madonna, R.; Zito, C.; Bronte, E.; Badalamenti, G.; Parrella, P.; Monte, I.; Tocchetti, C.; Russo, A.; Novo, G.
Cardiotoxic Effects of Anti-VEGFR Tyrosine Kinase Inhibitors
2016-01-01 Bronte, E.; Galvano, A.; Novo, G.; Russo, A.
Cardiotoxicity mechanisms of the combination of BRAF-inhibitors and MEK-inhibitors
2018-01-01 Bronte, Enrico*; Bronte, Giuseppe; Novo, Giuseppina; Rinaldi, Gaetana; Bronte, Fabrizio; Passiglia, Francesco; Russo, Antonio
Cardiovascular Toxicity in Cancer Patients Treated with Tyrosine Kinase Inhibitors: A Real-World Single-Center Experience
2020-01-01 Novo G.; Di Lisi D.; Bronte E.; MacAione F.; Accurso V.; Badalamenti G.; Rinaldi G.; Siragusa S.; Novo S.; Russo A.
Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy
2015-01-01 Bronte, G; Bronte, E; Novo, G; Pernice, G; Lo Vullo, F; Musso, E; Bronte, F; Gulotta, E; Rizzo, S; Rolfo, C; Silvestris, N; Bazan, V; Novo, S; Russo, A
E26The effects of LIPUS on ctDNA release in the medium of NSCLC cell lines
2017-01-01 Perez, A.; DI STEFANO, A.; Castiglia, M.; Sorrentino, M.; Matranga, D.; Grisafi, F.; Corso, C.; Scoarughi, G.; Barbato, G.; Barraco, N.; Calo', V.; DI PIAZZA, F.; Massihnia, D.; Listi', A.; Castellana, L.; Guarini, A.; Insalaco, L.; Bronte, E.; Russo, A.
HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma
2016-01-01 Bronte, F.; Bronte, G.; Fanale, D.; Caruso, S.; Bronte, E.; Bavetta, M.; Fiorentino, E.; Rolfo, C.; Bazan, V.; Marco, V.; Russo, A.
Immuno-targeted combinations in oncogene-addicted non-small cell lung cancer
2018-01-01 Angela Listì, Nadia Barraco, Marco Bono, Lavinia Insalaco, Luisa Castellana, Sofia Cutaia, Maria Rita Ricciardi, Valerio Gristina, Enrico Bronte, Gianni Pantuso, Francesco Passiglia,
Into the wild of long non-coding RNA in gastrointestinal stromal tumors (GISTs) to explore new prognostic/predictive biomarkers
2015-01-01 Barraco, N; BAZAN, V; Perez, A; BADALAMENTI, G; FULFARO, F; CASTIGLIA, M; BRONTE, G; BRONTE, E; INSALACO, L; Cangemi, A; INCORVAIA, L; RUSSO, A
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR- mutation testing in NSCLC patients: a pooled analysis
2018-01-01 Passiglia F, Rizzo S, Rolfo C, Galvano A, Bronte E, Incorvaia L, Listi A, Barraco N, Castiglia M, Calo V, Bazan V, Russo A.
Role of curcumin in idiopathic pulmonary arterial hypertension treatment: A new therapeutic possibility
2013-01-01 Bronte, E; Coppola, G; Di Miceli, R; Sucato, V; Russo, A; Novo, S
Targeted Therapies in Hepatocellular Carcinoma
2014-01-01 Bronte, F.; Bronte, G.; Cusenza, S.; Fiorentino, E.; Rolfo, C.; Cicero, G.; Bronte, E.; DI MARCO, V.; Firenze, A.; Angarano, G.; Fontana, T.; Russo, A.
The prognostic role of KRAS and BRAF in patients undergoing surgical resection of colorectal cancer liver metastasis: a systematic review and meta-analysis
2016-01-01 Passiglia, F; Galvano, A; Rizzo, S; Listì, A; Barraco, N; Insalaco, L; Bronte, E; Alessi, I; Guarini, A; Terruso, L; Castellana, L; Perez, A; Massihnia, D; Di Piazza, F; Calò, V; Castiglia, M; Bazan, V; Russo, A
What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment
2015-01-01 Bronte, E.; Bronte, G.; Novo, G.; Bronte, F.; Bavetta, M.; Re, G.; Brancatelli, G.; Bazan, V.; Natoli, C.; Novo, S.; Russo, A.